Moreover, polymorphisms in NOD2 and aberrant NOD2 signalling are identified as major susceptibility factors of several inflammatory disorders such as Crohn’s disease, Blau syndrome, early onset sarcoidosis, autoimmune disease, allergy and asthma4. This evidence concerns the gene NOD2 and sarcoidosis.